FDA Approves Expanded Use of Cresemba (isavuconazonium sulfate) in Children with Invasive Aspergillosis and Invasive Mucormycosis
Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections
Approval based on results of two pediatric studies in children aged 1 to...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news